Immatics (IMTX) Current Leases (2019 - 2025)
Immatics' (IMTX) quarterly Current Leases came in at $3.2 million in Q4 2025, up 5.34% year-on-year from $3.0 million in Q4 2024, and up 5.34% quarter-over-quarter from $3.0 million in Q4 2024.
Immatics (IMTX) Current Leases (2019 - 2025) Analysis & Trends
Immatics has disclosed Current Leases across 7 years of filings, most recently posting $3.2 million for Q4 2025.
- Current Leases for Q4 2025 came in at $3.2 million, up 5.34% year-over-year; the trailing twelve-month figure through Dec 2025 was $3.2 million (up 5.34% YoY), and the FY2025 annual result was $3.1 million, up 2.24% from the prior year.
- Current Leases came in at $3.2 million for Q4 2025 at Immatics, up from $3.0 million in the prior quarter.
- In the past five years, Current Leases ranged from a high of $3.2 million in Q4 2025 to a low of $2.2 million in Q4 2022.
- The 5-year median for Current Leases is $3.0 million (2024), against an average of $2.9 million.
- Across the five-year window, Current Leases surged 38.28% in 2021 and dropped 28.97% in 2022, its largest moves.
- Immatics' Current Leases stood at $3.1 million in 2021, then fell by 28.97% to $2.2 million in 2022, then advanced by 27.2% to $2.8 million in 2023, then gained by 8.74% to $3.0 million in 2024, then grew by 5.34% to $3.2 million in 2025.
- The last three Current Leases figures came in at $3.2 million (Q4 2025), $3.0 million (Q4 2024), and $2.8 million (Q4 2023), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | 42,980.09 |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 83,991.00 |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 7.40 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | Immatics | 14.67 Bn | 14.67 Bn | - | 3.21 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 3.21 Mn |
| Dec 31, 2024 | 3.05 Mn |
| Dec 31, 2023 | 2.80 Mn |
| Dec 31, 2022 | 2.20 Mn |
| Dec 31, 2021 | 3.10 Mn |
| Dec 31, 2020 | 2.24 Mn |
| Dec 31, 2019 | 1.56 Mn |